Sponsor:
Exelixis
Code:
NCT06545331
Conditions
Locally Advanced or Metastatic Solid Tumors
Esophageal Squamous Cell Cancer
Head and Neck Squamous Cell Cancer
NSCLC (Non-small Cell Lung Cancer)
Hormone-receptor-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
XB010
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-03. This information was provided to ClinicalTrials.gov by Exelixis on 2025-09-24.